Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Breast 10Gastrointestinal 9Thoracic 6Head & Neck 3Genitourinary 3CNS 3Dermatologic 2Sarcoma 1Lymphoid 1Gynecologic 1

Conditions

Glioma 2Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Diagnostic Imaging × CNS × Clear all
NCT06381531 2025-04-11

TRACE

Tata Memorial Centre

Recruiting
10,000 enrolled
CNS

Brain Neoplasms, Neoplasms, Central Nervous System Neoplasms

NCT05274919 2025-03-10

VASIM

Leiden University Medical Center

Recruiting
180 enrolled
CNS

Glioma

NCT00137488 2016-02-26

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

AHS Cancer Control Alberta

Completed
10 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡